Women With Multiple Sclerosis Show Increased Migraine Risk Before Symptom Onset
Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the onset of MS symptoms. Women with multiple sclerosis (MS) show increased risk for migraine for up to a decade prior to MS symptom onset, according to study results published in The Journal of Headache and Pain.
New Study Links Multiple Sclerosis to Increased Mental Health Risks During and After Pregnancy
A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during pregnancy and the first year after childbirth, compared to those without MS.
Menopause May Increase The Progression Of Multiple Sclerosis In Women, Study Warns
A recent study shows that menopause may worsen Multiple Sclerosis symptoms and accelerate its progression due to a decline in strogen levels
Pregnancy raises risks to mental health in MS patients, study says
Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.
Multiple sclerosis linked to increased risk of perinatal mental illness
People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births in Ontario.
Pregnancy Increases Mental Health Risk in MS Patients
Pregnancy increases the risk of mental illness among women with multiple sclerosis (MS). Pregnant MS patients have a higher risk of mental illness both during gestation and in the first years after they give birth,
devdiscourse20h
Breakthrough Drug Offers New Hope for Restoring Vision in MS Patients
Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...
FDA warns of serious allergic reactions with some multiple sclerosis drugs
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
BioSpace3d
FDA Tacks Boxed Warning on Teva’s Copaxone, Other MS Drugs
The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...
FiercePharma3d
Teva's multiple sclerosis stalwart Copaxone gets FDA boxed warning for anaphylaxis risk
After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...
FOX 9 Minneapolis-St. Paul on MSN1d
Edina, Minnetonka high school basketball rivals team up to ‘beat’ MS
The Minnetonka and Edina Girls Basketball teams are rivals on the court, but now they are joining forces to defeat a common ...
FDA warns of serious allergic reactions with multiple sclerosis drugs
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
The American Journal of Managed Care3d
FDA Warns of Severe Allergic Reactions With Certain Multiple Sclerosis Drugs
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
Medicare patients seeking neurology appointment face weekslong wait
The median wait time between referral and appointment was 34 days, and 18 percent of patients waited more than 90 days, the ...